ÂÜÀòÂÒÂ×

Andrew Hammond is a co-founder and the Head of R&D at Biocentis, a biotechnology company focused on developing genetic solutions for controlling harmful insect populations. Alongside this role, Andrew serves as an Honorary Senior Lecturer at Imperial College London and as a Senior Associate at the Johns Hopkins Bloomberg School of Public Health, contributing to both undergraduate and graduate education. Previous positions include Sir Henry Wellcome Research Fellow at both Johns Hopkins and Imperial College, where Andrew researched malaria transmission and engaged in public science communication regarding ethical issues in genetic engineering. Andrew holds a PhD in Cell and Molecular Biology and a BSc in Biology from Imperial College London.